IL-6 is essential in TNF-alpha-induced fever

Am J Physiol. 1998 Dec;275(6):R2028-34. doi: 10.1152/ajpregu.1998.275.6.R2028.

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is a pleiotropic cytokine that orchestrates an array of local and systemic effects. For instance, acute exposure to a high dose of TNF-alpha results in septic shock and fever. We have used interleukin-1beta (IL-1beta)- and interleukin-6 (IL-6)-deficient mice, along with their wild-type equivalents, to define a role for TNF-alpha in fever. Briefly, the mice produced prostaglandin E2-dependent fevers in response to recombinant murine TNF-alpha (rmTNF-alpha). Furthermore, rmTNF-alpha (12 microgram/mouse ip) triggered a febrile response in IL-1beta-deficient mice as well as in their corresponding wild-type controls. In contrast, the IL-6-deficient mice were resistant to rmTNF-alpha (4.5 microgram/mouse ip), although their wild-type counterparts readily mounted a fever. In the IL-6-deficient mice, moreover, the febrile response to rmTNF-alpha could be restored by a central administration of rat recombinant IL-6 (500 ng/mouse icv). We thus conclude that TNF-alpha can trigger fever independent of IL-1beta but dependent on IL-6. We also suggest that central, rather than peripheral, IL-6 (plasma IL-6 was measured 2 h after pyrogenic challenge) is essential in TNF-alpha-induced fever.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Fever / chemically induced*
  • Fever / physiopathology*
  • Humans
  • Injections, Intraperitoneal
  • Injections, Intraventricular
  • Interleukin-1 / deficiency
  • Interleukin-1 / genetics
  • Interleukin-6 / deficiency
  • Interleukin-6 / genetics
  • Interleukin-6 / pharmacology
  • Interleukin-6 / physiology*
  • Male
  • Mice
  • Mice, Knockout / genetics
  • Rats
  • Recombinant Proteins
  • Reference Values
  • Tumor Necrosis Factor-alpha* / pharmacology

Substances

  • Interleukin-1
  • Interleukin-6
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha